Graphite Bio, Inc. announced that it will issue 45,024,986 series A preferred shares at a price of $1 per share for gross proceeds of $45,024,986 on June 23, 2020. The shares carry non-cumulative fixed dividend rate of 8% per annum. The shares are convertible into common shares of the company at a fixed conversion price of $1 per share.